Pub. Date : 2021 Dec
PMID : 34472693
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Benefit of Insulin Glargine/Lixisenatide for Reducing Residual Hyperglycaemia in Japan: Post-Hoc Analysis of the LixiLan JP-O2 Trial. | Insulin Glargine | insulin | Homo sapiens |
| 2 | AIMS: To compare the benefits of iGlarLixi, a fixed-ratio combination of insulin glargine 100 U/mL and lixisenatide (iGlarLixi), over insulin glargine (iGlar) for reducing residual hyperglycaemia (defined as glycated haemoglobin (HbA1c) >=7% despite fasting plasma glucose (FPG) <130 mg/dL) in Japanese people with type 2 diabetes (T2D) inadequately controlled on oral antidiabetic drugs. | Insulin Glargine | insulin | Homo sapiens |